EMIS The European MSM Internet Survey Contract No Deliverable No.11: Dissemination
|
|
|
- Asher Davidson
- 5 years ago
- Views:
Transcription
1 EMIS The European MSM Internet Survey Contract No Deliverable No.11: Dissemination For more information, please contact the scientific coordinator Axel J. Schmidt
2 1. Community Report Language Versions Bulgarian Croatian Czech Danish Dutch English Estonian Finnish French German Greek Ireland Italian Latvian Lithuanian Norwegian Polish Portuguese Romanian Russian Slovak Slovenian Spanish Swedish Turkish 2. Community Report Language Versions Bulgarian Czech Danish Dutch English
3 2.1.6 Estonian Finnish French German Greek Hungarian Italian Latvian Lithuanian Norwegian Polish Portuguese Romanian Russian Serbian Slovak Slovenian Spanish Swedish Turkish 3. National Reports 3.1 Countries Russia German UK Tba of 16 country reports: AT, BE, BG, CH, CZ, DK, EE, ES, IE, LT, LV, NO, PL, PT, SI, UA 4. Joint Scientific Report Tba 5. Ungass Report 5.1 Language Versions English Russian
4 6. Conference Outputs 6.1 CEEISCAT Tallin 2011 Knowledge 6.2 IAS2010 EMIS Methods and Response 6.3 MedReport Rationalizing HIV Testing Strategies 6.4 MedReport Why European Cities Need Sexual Health Center for Gay Men 6.5 Poster Circoncisión (SEISIDA) 6.6 Poster EMIS SEISIDA P Poster Late HIV diagnosis in Spain 6.8 RegVen ICAR 2011 UNGASS Indicators 6.9 Presentation for Vulnerabiliy and HIV in Europe, Spain The European MSM Internet Survey 6.10 Presentation for FEMP, Sweden - Building a Network for Harmonised European Research on prevention of HIV and STIs among MSM 7. Publications (other) and news 7.1 Ondamaris: Anale Untersuchungen häufig Mangelware (German) Queer: Absage an die Bareback-Propheten (German) GAT Portugal Skapis (Czech) Skapis (Russian) LUI: V roce 2009 (Czech) ziskali-ei-spolu-s-maary-stibrnou-medaili.html 7.7 Aidsmap: Wide variation in quality of sexual health screening across Europe; countries with specialised clinics do better (English)
5 Europe-countries-with-specialised-clinics-do-better/page/ / 7.8 SPY: The First Results of EMIS Research Published (English/Serbia) objavljeni-prvi-rezultati-emis-istrazivanja 7.9 MOSinforma (Italian) Narobe (Slovenian) Mladina (Slovenian) Siegessäule: 7.13 ILGA: The European MSM Internet Survey (EMIS) - 1º Relatório Comunitário (Portuguese) Gaynews (Italian) EMIS-Umfrage: rund 62 % mit Sexleben zufrieden (German) Queerblog: Ricerca EMIS (Italian) Portugalgay (Portuguese) Aidshilfe: Großer Erfolg: Erste Ergebnisse der EMIS-Befragung veröffentlicht (German) Arcigay Verona (Italian)
6 7.19 Nada contra corrente (Portuguese) 7.20 Limburgs Aktiecentrum Homofilie (Dutch) Gayby.net (Russian) Anders Des Te Beter (Dutch) Dezanove (Portuguese) Jihoceská Lambda (Latvian) Apvieniba LIV (Latvian) b=1&lbu= Delfi (Latvian) 12:hiv-e-uomini-gaybisessuali-i-primi-risultati-di-emis&catid=96:hiv-eaids&Itemid= Apollo (Latvian) LukLife (Czech) cz (Czech) Wel jong niet hetero (Dutch) Colour Planet (Czech)
7 7.32 GayNet (Czech) GaTe (Czech) Pinkmap (German) Queer: Ansturm auf die Sexumfrage (German) The HIV Support Centre (English) iwwit (German) Ondamaris: Auf die Größe kommt es an (German) Ggg.at (German) Ondamaris: EMIS europaweite Befragung von Männern, die Sex mit Männern haben Gayby.net (Belarusian) GHN: On the one road Issue 10 - Manchester Conference (English) GHN: On the one road Issue 12 (English) Latvian Infectology Centre (Latvian)
8 7.45 Gay Barcelona Terrence Higgins Trust
24-7 Emergency line service (English)
Emergency Line 24-7 Emergency line service (English) 1. Incident occurs 2. Caller dials 24-7 Specialist Advice Number. Incident Advisors hear whisper from automated phone system and are connected to caller
Address Tel: Fax:
Address: Athena Court, Office 32, 3 rd floor, 2 Americanas Street,Potamos Yermasoyias, 4048 Limassol- Cyprus P.O.Box 51673 CY-3507 Limasol - Cyprus Tel: +357 25 325544 Fax: +357 25 318885 Email: info@interbrics.com
Lingmo Translate Manual Smartphone / Tablet
Lingmo Translate Manual Smartphone / Tablet Don t Translate it. Lingmo It! language translation technology for the global market 1 Accurate 2 way Translation from your Smart Device Translate spoken and
Scheduler API (TIMETABLE_PLUGIN)
Page 1 of 18 Scheduler API (TIMETABLE_PLUGIN) V 1.6 2018-03-06 Page 2 of 18 Table of Contents Document history 3 Foreword 4 Scheduler API (TIMETABLE_PLUGIN) introduction 5 HTTP Request Definitions 6 2.1
20 June 2018 Our Ref: RFI 23569
Information Governance 20 June 2018 Our Ref: RFI 23569 Dear Freedom of Information Act 2000 Information in Relation to Translator Costs I am writing to confirm that the South Eastern Health & Social Care
27 Sept Jul. 1991
111 th Anniversary 27 Sept.1907 26 Jul. 1991 Herbal Calendar 2019 Kräuterkalender 2019 14 Calendar Spreads Dimensions: 300 x 300 mm Publication Date: August 2018 The very first Treben wall calendar! ISBN
European Day of Languages QUIZ
European Day of Languages QUIZ 1. How many living languages are there estimated in the world today? a. Around 500 b. Around 2000 c. Around 6000 d. Around 3500 There are between 6000 and 7000 languages
Public summary of opinion on orphan designation
13 December 2016 EMA/682756/2016 Committee for Orphan Medicinal Products Gly-Asp-Leu-Leu-Pro-Arg-Gly- Ser for the treatment of s disease On 18 November 2016, orphan designation (EU/3/16/1790) was granted
Languages spoken by residents in the City of Knox
Languages spoken by residents in the City of Knox There is a total 149301 people living in the City of Knox. 76% (114025) of people speak English at home whilst 21% (31227) speak a language other than
Fieldwork: February March 2010 Publication: October 2010
Special Eurobarometer 345 European Commission Mental Health Part 1: Report Fieldwork: February March 2010 Publication: October 2010 Special Eurobarometer 345 / Wave 73.2 TNS Opinion & Social This survey
Public summary of opinion on orphan designation
21 January 2014 EMA/COMP/703237/2013 Committee for Orphan Medicinal Products and for the prevention of necrotising enterocolitis On 16 January 2014, orphan designation (EU/3/13/1213) was granted by the
Language Services / Tasks
Athena Kartalou Language Services Manager Games Services Special Olympics ATHENS 2011 Language Services / Tasks To provide linguistic services to delegations coming from all over the world. To cover as
CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY
CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY myesr.org QUALITY & SAFETY Improving and harmonising quality and safety in medical imaging across Europe
Young people and drugs. Analytical report
Flash Eurobarometer European Commission Young people and drugs among 15-24 year-olds Analytical report Fieldwork: May 2008 Report: May 2008 Flash Eurobarometer 233 The Gallup Organization This survey was
Public summary of opinion on orphan designation
22 November 2018 EMA/514601/2018 hydroxy-6,9-dimethyl- 3,3a,4,5,7,8,9,9a-octahydroazuleno[4,5-b]furan-2(9bH)-one fumarate for the treatment of glioma On 24 August 2018, orphan designation (EU/3/18/2055)
Public summary of opinion on orphan designation
10 November 2014 EMA/COMP/557455/2014 Committee for Orphan Medicinal Products dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile for the treatment of pemphigus On 15 October 2014, orphan designation (EU/3/14/1335)
Public summary of opinion on orphan designation
21 May 2015 EMA/COMP/252166/2014 Rev.1 Committee for Orphan Medicinal Products Paclitaxel-succinate-Arg-Arg-Leu-Ser-Tyr-Ser-Arg- for the treatment of glioma First publication 2 July 2014 Rev.1: transfer
Public summary of opinion on orphan designation
19 February 2015 EMA/COMP/724036/2014 Committee for Orphan Medicinal Products 5-bromo-N-(prop-2-yn-1-yl)-2-(1H-1,2,4-triazol-1-yl)pyrimidine-4,6-diamine for the treatment of s disease On 16 December 2014,
FREEDOM OF INFORMATION REQUEST
FREEDOM OF INFORMATION REQUEST Request Number: F-2010-00380 Keyword: Finance Subject: Interpreting/Translation Request and : This is to inform you that the Police Service of Northern Ireland has now completed
Public summary of opinion on orphan designation
20 June 2016 EMA/COMP/314054/2016 Committee for Orphan Medicinal Products 2-propen-1-yl]-1- piperazinecarboxamide for the treatment of retinitis On 30 May 2016, orphan designation (EU/3/16/1658) was granted
Public summary of opinion on orphan designation
12 October 2010 EMA/COMP/455242/2010 Committee for Orphan Medicinal Products N-(6-(2-aminophenylamino)-6- for the treatment of Friedreich s ataxia On 1 October 2010, orphan designation (EU/3/10/793) was
Public summary of opinion on orphan designation
6 May 2015 EMA/COMP/116731/2015 Committee for Orphan Medicinal Products methylsulfanylphenyl)-3,1-benzoxazin-4-one for the treatment of Netherton syndrome On 19 March 2015, orphan designation (EU/3/15/1454)
Public summary of opinion on orphan designation
11 August 2017 EMA/402771/2017 Bacillus oxalate decarboxylase for the treatment of primary hyperoxaluria On 17 July 2017, orphan designation (EU/3/17/1891) was granted by the European Commission to Allena
Translation User Manual. Don t Translate it. Lingmo it! Leading edge language translation technology for the global market
Translation User Manual Don t Translate it. Lingmo it! Leading edge language translation technology for the global market Contents About T2T Translation Software Your Time2Translate Charging your Time2Translate
Public summary of opinion on orphan designation
19 May 2015 EMA/COMP/205588/2015 Committee for Orphan Medicinal Products bis(1,1-dimethylethyl) monohydrochloride for the treatment of s disease On 24 April 2015, orphan designation (EU/3/15/1481) was
School Curriculum and Standards Authority
Accounting and Finance Stage 2-74 42 12 57 9 43 21-50 Accounting and Finance Stage 3-1366 1181 596 48 635 52 1231 4.2 Ancient History Stage 2-4 10 2 40 3 60 5-50 Ancient History Stage 3-200 212 92 60 62
Geriatric Grand Rounds
Geriatric Grand Rounds Screening for Dementia in a Multicultural Context Zahinoor Ismail BMSc MD FRCPC Tuesday, June 15, 2010 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping
MEMORANDUM. June 30, 2017
MEMORANDUM June 30, 2017 To: From: Re: Area, District, and Central Office/Intergroup Literature Chairpersons Sandra Wilson, Literature Coordinator (212) 870-3019; E-mail: literature@aa.org Literature Activity
Public summary of opinion on orphan designation
8 March 2017 EMA/5008/2017 Committee for Orphan Medicinal Products [5,10,15,20-tetrakis(4-carboxyphenyl)-21H,23H-porphine]manganese(III) e for the treatment of syndrome On 12 January 2017, orphan designation
Suicide prevention from a global perspective Dr Alexandra Fleischmann Department of Mental Health and Substance Abuse World Health Organization
San José, Costa Rica, May 2016 Suicide prevention from a global perspective Dr Alexandra Fleischmann Department of Mental Health and Substance Abuse World Health Organization Suicide facts (1) Over 800
Public summary of opinion on orphan designation
12 January 2015 EMA/COMP/645261/2014 Committee for Orphan Medicinal Products (3S)-1-azabicyclo[2.2.2]oct-3-yl{2-[2-(4-fluorophenyl)-1,3-thiazol-4- yl]propan-2- for the treatment of disease On 19 November
Public summary of opinion on orphan designation
20 June 2016 EMA/COMP/309638/2016 Committee for Orphan Medicinal Products for the treatment of biliary tract cancer On 30 May 2016, orphan designation (EU/3/16/1657) was granted by the European Commission
Public summary of opinion on orphan designation
27 April 2016 EMA/COMP/172769/2016 Committee for Orphan Medicinal Products Fosbretabulin tromethamine for the treatment of gastro-entero-pancreatic neuroendocrine tumours On 21 March 2016, orphan designation
Public summary of opinion on orphan designation
29 February 2012 EMA/COMP/41120/2012 Committee for Orphan Medicinal Products (1S,3S)-3-amino-4-(difluoromethylene) cyclopentanecarboxylic acid hydrochloride for the treatment of West syndrome On 9 February
Public summary of opinion on orphan designation
30 March 2015 EMA/COMP/26647/2015 Committee for Orphan Medicinal Products Recombinant human glutamate oxaloacetate for the treatment of glioma On 12 February 2015, orphan designation (EU/3/15/1443) was
Public summary of opinion on orphan designation
3 May 2017 EMA/143980/2017 Committee for Orphan Medicinal Products Poly-cyclodextrin-bis-cysteine-PEG 3400 -camptothecin-conjugate for the treatment of ovarian cancer On 20 March 2017, orphan designation
Committee for Orphan Medicinal Products
European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use Document Date: London, 13 May 2009 Doc.Ref.: EMEA/COMP/229279/2008 Please note that this product was withdrawn from the
Public summary of opinion on orphan designation
3 March 2015 EMA/COMP/160599/2008 Rev.2 Committee for Orphan Medicinal Products [Nle4, D-Phe7]-alpha-melanocyte stimulating e for the treatment of erythropoietic protoporphyria First publication 29 July
Media monitoring: Experience of outbreak monitoring at ECDC to monitor vaccine safety potential crisis- A pilot using MediSYS
Media monitoring: Experience of outbreak monitoring at ECDC to monitor vaccine safety potential crisis- A pilot using MediSYS Building Trust, Managing Risk: Vaccine Confidence and Human Papillomavirus
Summer 2016 Examinations Timetable. Pm exams start 13:30 + Period Day / Date Period 1 Period 2 Period 3 Period 4.
02/05/16 03/05/16 English as First Language reading - 1hr 45m (12) 04/05/16 05/05/16 06/05/16 English as First Language writing 2 hours (12) 09/05/16 10/05/16 11/05/16 12/05/16 13/05/16 Welsh as Second
Public summary of opinion on orphan designation
16 October 2017 EMA/475685/2017 Itraconazole for the treatment of naevoid basal-cell carcinoma syndrome (Gorlin syndrome) On 23 August 2017, orphan designation (EU/3/17/1901) was granted by the European
Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys
Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys Wim Vanden Berghe ITM HIV/AIDS center Department of Public Health Institute of
Public summary of opinion on orphan designation
14 August 2013 EMA/COMP/402338/2013 Committee for Orphan Medicinal Products (1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N -bis(2- bromoethyl)diamidophosphate for the treatment of pancreatic cancer On
Public summary of opinion on orphan designation
25 September 2012 EMA/COMP/526568/2012 Committee for Orphan Medicinal Products 2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-(4- hydroxyphenyl)acetyl]amino}butanoic acid for the treatment of syndrome On
Public summary of opinion on orphan designation
13 April 2015 EMA/COMP/628335/2008 Rev.4 Committee for Orphan Medicinal Products methyl-3-pyridinyl)ethyl]-1hpyrido[4,3-b]indole e for the treatment of s disease First publication 16 February 2009 Rev.1:
NEW LEARNING ENVIRONMENTS THE EUROPEAN LEARNING SPACE NATIONAL REPORT POLAND. Bogusław Marek
NEW LEARNING ENVIRONMENTS THE EUROPEAN LEARNING SPACE NATIONAL REPORT POLAND Bogusław Marek 1. General Introduction. Foreign languages have in the long last become an important part in the study programmes
Public summary of opinion on orphan designation
25 April 2014 EMA/COMP/127723/2008 Rev.2 Committee for Orphan Medicinal Products 5'-O-(trans-9"-octadecenoyl)-1-ß-D-arabinofuranosyl cytosine for the treatment of acute myeloid leukaemia First publication
Public summary of opinion on orphan designation
6 March 2015 EMA/COMP/173924/2008 Rev.1 Committee for Orphan Medicinal Products Thio] (CCCTG for the treatment of acute myeloid leukaemia First publication 1 April 2009 Rev.1: sponsor s change of address
COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 27.6.2008 COM(2008) 393 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL ON THE IMPLEMENTATION OF ARTICLE 9 OF COUNCIL
Public summary of opinion on orphan designation
7 November 2016 EMA/628404/2016 Committee for Orphan Medicinal Products fluoro-pyrimidin-2- yl)piperazin-1-yl]-phenyl}-2-oxo-acetamide for the treatment of invasive aspergillosis On 14 October 2016, orphan
Public summary of opinion on orphan designation
11 June 2010 EMA/COMP/315308/2005 Rev.2 Committee for Orphan Medicinal Products peptide 144 TGF-beta1-inhibitor for the treatment of systemic sclerosis On 28 October 2005, orphan designation (EU/3/05/326)
Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)
Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Guidelines for Users May 2016 B1 Chorlton Mill, 3 Cambridge Street, Manchester, M1 5BY, UK Tel: +44 (0)161 226 4446 Fax: +44
Public summary of opinion on orphan designation
11 June 2010 EMA/COMP/317440/2005 Rev.2 Committee for Orphan Medicinal Products peptide 144 TGF-beta1-inhibitor for the localised scleroderma On 28 October 2005, orphan designation (EU/3/05/329) was granted
COMMITTEE FOR ORPHAN MEDICINAL PRODUCTS PUBLIC SUMMARY OF POSITIVE OPINION FOR ORPHAN DESIGNATION OF
European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use Document Date: London, 21 January 2008 Doc.Ref.: EMEA/COMP/388117/2007 COMMITTEE FOR ORPHAN MEDICINAL PRODUCTS PUBLIC SUMMARY
Public summary of opinion on orphan designation
18 February 2013 EMA/COMP/798800/2012 Committee for Orphan Medicinal Products Eflornithine in combination with for the treatment of familial adenomatous polyposis On 24 January 2013, orphan designation
Supplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Cohen DJ, Van Hout B, Serruys PW, et al. Quality of life after
COMMITTEE FOR ORPHAN MEDICINAL PRODUCTS PUBLIC SUMMARY OF POSITIVE OPINION FOR ORPHAN DESIGNATION OF
European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use Document Date: London, 18 July 2007 Doc.Ref.: EMEA/COMP/165106/2007 COMMITTEE FOR ORPHAN MEDICINAL PRODUCTS PUBLIC SUMMARY
Public summary of opinion on orphan designation
6 March 2015 EMA/COMP/221961/2008 Rev.2 Committee for Orphan Medicinal Products Iodine ( 131 I) anti-tenascin monoclonal antibody 81C6 for the treatment of glioma First publication 15 June 2009 Rev.1:
Public summary of opinion on orphan designation
27 May 2016 EMA/COMP/254160/2016 Committee for Orphan Medicinal Products {[2- (trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol methanesulfonate for the treatment of acute myeloid
Public summary of opinion on orphan designation
27 May 2016 EMA/COMP/254123/2016 Committee for Orphan Medicinal Products Met-Phe-Pro-Asn- Ala-Pro-Tyr-Leu-Pro-Ser-Cys-Leu-Glu-Ser, Arg-Ser-Asp-Glu-Leu-Val-Arg-His- His-Asn-Met-His-Gln-Arg-Asn-Met-Thr-Lys-Leu
Public summary of opinion on orphan designation
12 January 2015 EMA/COMP/637435/2014 Committee for Orphan Medicinal Products fluoro-6- methylbenzoyl)piperidine-3-carboxylic acid(4-methyl-3- trifluoromethylphenyl)amide for the treatment of microscopic
European Day of Languages QUIZ 1 - World languages and linguistics ANSWERS
European Day of Languages QUIZ 1 - World languages and linguistics ANSWERS 1c There are between 6000 and 7000 languages in the world - spoken by six billion people divided into 189 independent states.
Table 1: Home Languages across Six States Note: Pathways to college materials are available for languages in bold at
Cultural Bridges to College: Mapping Pathways to College in Families Home Nancy Trinh, Kim Tsai, and Catherine R. Cooper (2007). Department of Psychology, University of California, Santa Cruz www.bridgingworlds.org
Rehabilitation Catalogue
Rehabilitation Rehabilitation Catalogue Resources for Parents, Recipients and Professionals At MED-EL, we understand that providing the best possible hearing implant solution is only one essential element
ONLINE RESOURCES. The National Standards for Culturally and Linguistically Appropriate Services in
1.9 HOURS Continuing Education ONLINE RESOURCES for Culturally and Linguistically Appropriate Services in Home Healthcare and Hospice PART 4: RESOURCES FOR EUROPEAN PATIENTS Provision of culturally and
Public summary of opinion on orphan designation
12 August 2015 EMA/COMP/432825/2015 Committee for Orphan Medicinal Products Triheptanoin for the treatment of long-chain 3-hydroxyacyl-coA dehydrogenase deficiency On 28 July 2015, orphan designation (EU/3/15/1524)
Formative Research results
FRR Annex 5: Presentation of the FR results in the project meeting, Berlin, 11. 13.02.2013 Formative Research results Sandra Dudareva Vizule, Ulrich Marcus Robert Koch Institute 11 February 2013 Content
Public summary of opinion on orphan designation
2 February 2016 EMA/COMP/844899/2015 Committee for Orphan Medicinal Products yl)pyrazolo[1,5-a]pyrimidin- 3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate for the treatment of soft tissue sarcoma
Public summary of opinion on orphan designation
24 April 2012 EMA/COMP/136271/2012 Committee for Orphan Medicinal Products Genistein sodium salt dihydrate for the treatment of mucopolysaccharidosis type III (Sanfilippo syndrome) On 2 April 2012, orphan
HIV/AIDS Joint Action HA-REACT
HIV/AIDS Joint Action HA-REACT Matthias Schuppe Policy Officer Health Threats Unit DG Health and Food Safety European Commission Policy Framework on HIV/AIDS in EU and neighbouring countries Commission
CITY OF AURORA - LANGUAGE ASSISTANCE PLAN (LAP)
CITY OF AURORA - LANGUAGE ASSISTANCE PLAN (LAP) Four-Factor Analysis of persons with Limited English Proficiency (LEP): 1. Demography Number or Proportion of LEP Persons The number and proportion of LEP
Annual Report Gay Health Network (GHN)
Annual Report 2013 Gay Health Network (GHN) ABOUT THE GAY HEALTH NETWORK (GHN) GHN is an All-Ireland network of organisations and individuals with a shared ethos and commitment to achieving the purpose
Public summary of opinion on orphan designation
6 April 2018 EMA/60711/2018 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7- yl]oxy]methyl]cyclopropanamine-dihydrochloride for the treatment of soft tissue sarcoma On 22 February 2018,
Public summary of opinion on orphan designation
6 April 2018 EMA/71251/2018 Mertansine functionalised gold nanoconjugate for the treatment of hepatocellular carcinoma On 22 February 2018, orphan designation (EU/3/18/1981) was granted by the European
Summary. The 2007 ESPAD report Substance use among students in 35 countries
Summary The 27 ESPAD report Substance use among students in 35 countries EN Legal notice This publication of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is protected by copyright.
SPECIAL EUROBAROMETER 332. Fieldwork: October 2009 Publication: May 2010
SPECIAL EUROBAROMETER 332 Special Eurobarometer 332 Tobacco European Commission Tobacco Fieldwork: October 2009 Publication: May 2010 Special Eurobarometer 332 / Wave TNS Opinion & Social This survey was
Public summary of opinion on orphan designation
7 November 2016 EMA/628398/2016 Committee for Orphan Medicinal Products tetrahydrocannabinol-9- carboxylic acid for the treatment of cystic fibrosis On 14 October 2016, orphan designation (EU/3/16/1736)
Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
Chronic urticaria: tools to aid the diagnosis and assessment of disease status in daily practice
DOI: 10.1111/jdv.13200 JEADV SECTION 6 Chronic urticaria: tools to aid the diagnosis and assessment of disease status in daily practice K. Weller, T. Zuberbier, M. Maurer* Department of Dermatology and
Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
Public summary of opinion on orphan designation
23 February 2015 EMA/COMP/733378/2014 Committee for Orphan Medicinal Products Pegylated recombinant human hyaluronidase for the treatment of pancreatic cancer On 16 December 2014, orphan designation (EU/3/14/1394)
Language Assistance Services Policy
Language Assistance Services Policy PURPOSE To provide 24 hour interpretation service for non-english speaking persons. POLICY The hospital attempts to eliminate communication barriers between hospitalstaff
Public summary of opinion on orphan designation
20 April 2015 EMA/COMP/272347/2013 Rev.1 Committee for Orphan Medicinal Products Recombinant human nerve growth factor for the treatment of retinitis pigmentosa First publication 18 June 2013 Rev.1: transfer
Screening programmes for Hepatitis B/C in Europe
Programme STI, HIV/AIDS and viral hepatitis Screening programmes for Hepatitis B/C in Europe Mika Salminen, Ph.D. European Centre for Disease Prevention and Control Why might screening be needed for hepatitis
Public summary of opinion on orphan designation
EMA/COMP/43230/2012 Rev.1 Committee for Orphan Medicinal Products Sodium phenylbutyrate for the treatment of carbamoyl-phosphate synthase- 1 deficiency First publication 29 February 2012 Rev.1: withdrawal
Public summary of opinion on orphan designation
13 October 2011 EMA/COMP/659363/2011 Committee for Orphan Medicinal Products for the treatment of traumatic spinal cord injury On 27 September 2011, orphan designation (EU/3/11/910) was granted by the
'SECTION B EU PARTY. The following abbreviations are used:
'SECTION B EU PARTY The following abbreviations are used: AT Austria BE Belgium BG Bulgaria CY Cyprus CZ Czech Republic DE Germany DK Denmark ES Spain EE Estonia EU European Union, including all its Member
New trends in harm reduction in Europe: progress made challenges ahead
New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm
Public summary of opinion on orphan designation
25 September 2012 EMA/COMP/526570/2012 Committee for Orphan Medicinal Products 2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-(4- hydroxyphenyl)acetyl]amino}butanoic acid for the treatment of primary biliary
Biglu M., Biglu S., J Anal Res Clin Med, 2014, 2(1), 1-10. doi: 10.5681/jarcm.2014.001 Review Article Scientific attitudes towards bipolar disorders Mohammad Hossein Biglu* 1, Sahar Biglu 2 1 Associate
DANA Ubiquitous Insulin Pump System
# R 메메메 메메메 메메메메:Layout 1 10. 09. 15 메메 4:45 Page 1 DANA Ubiquitous Insulin Pump System DANA Manager & DANA Mobile # R 메메메 메메메 메메메메:Layout 1 10. 09. 15 메메 4:46 Page 2 DANA Manager DANA MANAGER DANA Ubiquitous
Fieldwork October - November 2006 Publication March Report
Special Eurobarometer European Commission Attitudes towards Alcohol Fieldwork October - November 2006 Publication March 2007 Report Special Eurobarometer 272b / Wave 66.2 TNS Opinion & Social This survey
Public summary of opinion on orphan designation
26 February 2013 EMA/COMP/20734/2013 Committee for Orphan Medicinal Products Treprostinil sodium for the treatment of chronic thromboembolic pulmonary On 8 February 2013, orphan designation (EU/3/13/1103)
Public summary of opinion on orphan designation
6 March 2015 EMA/COMP/185530/2013 Rev.1 Committee for Orphan Medicinal Products R,S-O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride for the treatment of muscular dystrophy
Public summary of opinion on orphan designation
9 March 2015 EMA/COMP/804530/2009 Rev.2 Committee for Orphan Medicinal Products ylethynyl)-4-methyl-n-[4-[(4- methyl-1- for the treatment of chronic myeloid leukaemia First publication 2 March 2010 Rev.1:
Trends in injecting drug use in Europe
Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information
IDR FORM Susac Syndrome International Disease Registry (IDR)
IDR FORM Susac Syndrome International Disease Registry (IDR) CCF IRB #: 13-188 Patient IDR Code: This form is designed for a patient s physician to complete (with or without the help of the patient or
Table Of Content. Outputs... 10
Table Of Content MEANINGFUL HIV SURVEILLANCE AMONG MSM... 3 Summary... 4 Coordinator, Leader contact and partners... 6 Robert Koch Institute, Berlin... 6 National Institute of Infectious Diseases Prof.
Diagnosis of Neuropathic Pain. Didier Bouhassira
Diagnosis of Neuropathic Pain Didier Bouhassira INSERM U-792 Centre d Evaluation et de Traitement de la Douleur Hôpital Ambroise Paré, Boulogne-Billancourt FRANCE BPS, June 7, Brussels Definition Pain
31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million
31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million cancer cases Adult patients (age 15+) 45 major cancer sites